Manulife (Manufacturers Life Insurance)
BCYC

Manulife (Manufacturers Life Insurance)’s Bicycle Therapeutics BCYC Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$593K Hold
127,863
– – ﹤0.01% 2079
2025
Q4 		$869K Sell
127,863
-12,629
-9% -$93.1K ﹤0.01% 1922
2025
Q3 		$1.09M Hold
140,492
– – ﹤0.01% 1815
2025
Q2 		$976K Buy
140,492
+2,243
+2% +$17.9K ﹤0.01% 1836
2025
Q1 		$1.17M Buy
138,249
+13,752
+11% +$162K ﹤0.01% 1742
2024
Q4 		$1.74M Sell
124,497
-5,208
-4% -$112K ﹤0.01% 1631
2024
Q3 		$2.94M Buy
129,705
+32,313
+33% +$745K ﹤0.01% 1413
2024
Q2 		$1.97M Buy
97,392
+71,434
+275% +$1.61M ﹤0.01% 1499
2024
Q1 		$646K Buy
25,958
+12,785
+97% +$272K ﹤0.01% 2087
2023
Q4 		$238K Sell
13,173
-22,919
-64% -$379K ﹤0.01% 2527
2023
Q3 		$725K Buy
36,092
+10,956
+44% +$251K ﹤0.01% 1928
2023
Q2 		$641K Hold
25,136
– – ﹤0.01% 1896
2023
Q1 		$535K Hold
25,136
– – ﹤0.01% 1976
2022
Q4 		$743K Hold
25,136
– – ﹤0.01% 1757
2022
Q3 		$597K Hold
25,136
– – ﹤0.01% 1863
2022
Q2 		$431K Buy
25,136
+5,603
+29% +$118K ﹤0.01% 2156
2022
Q1 		$831K Buy
+19,533
New +$912K ﹤0.01% 1856

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BCYC Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) held its Bicycle Therapeutics (BCYC) position steady in Q1 2026 at 127,863 shares worth $593K. The position accounts for ﹤0.01% of the portfolio, ranked #2079.

Manulife (Manufacturers Life Insurance) first reported a position in BCYC in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.94M in Q3 2024. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 127,863 shares of Bicycle Therapeutics worth $593K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) left its Bicycle Therapeutics share count unchanged in Q1 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2079 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Bicycle Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Bicycle Therapeutics position peaked at $2.94M in Q3 2024.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.